Selgelid, Michael J.
Michael Selgelid
VIAF ID: 48666149 (Personal)
Permalink: http://viaf.org/viaf/48666149
Preferred Forms
- 100 0 _ ‡a Michael Selgelid
- 200 _ | ‡a Selgelid ‡b Michael J.
-
-
-
-
- 100 1 _ ‡a Selgelid, Michael J.
-
- 100 1 _ ‡a Selgelid, Michael J.
-
-
- 100 1 _ ‡a Selgelid, Michael J.
-
- 100 1 _ ‡a Selgelid, Michael J.
4xx's: Alternate Name Forms (6)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
After-birth abortion. | |
Biodefense and dual-use research: the optimisation problem and the value of security. | |
Bioterrorism and smallpox planning: information and voluntary vaccination. | |
Burden of Proof in Bioethics. | |
Capabilities and Incapabilities of the Capabilities Approach to Health Justice. | |
The Case for Mandatory Flu Vaccination of Children | |
Commentary: The Ethics of Dangerous Discovery | |
Conflicting clinical duties. | |
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine | |
Democratic defense spending in an age of bioterrorism | |
Disease Prevention and Control | |
Do patents prevent access to drugs for HIV in developing countries? | |
Dual-Use Research Codes of Conduct: Lessons from the Life Sciences | |
Emergency ethics | |
Ethical and Empirical Issues Concerning Conditional Treatment of Lead Poisoning from Gold Mining in Nigeria | |
Ethical and philosophical consideration of the dual-use dilemma in the biological sciences | |
Ethical aspects of malaria control and research | |
Ethical challenges in TB control in the era of XDR-TB | |
Ethical considerations for vaccination programmes in acute humanitarian emergencies | |
Ethical issues in tuberculosis diagnosis and treatment. | |
Ethics and drug resistance : collective responsibility for global public health | |
Ethics and infectious disease, c2006: | |
Ethics and research: the case of informed consent. | |
Ethics of controlled human infection to study COVID-19 | |
Freedom and moral enhancement. | |
FROM THE GUEST EDITORS | |
Gain-of-Function Research: Ethical Analysis | |
Governance of dual-use research: an ethical dilemma | |
Health rights | |
Human and nonhuman bioethics. | |
Human genetic enhancement has become one of the most controversial issues in bioethics during the past decade. | |
Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy | |
The importance of "throwing money at" the problem of global health | |
Improving global health: counting reasons why. | |
In that case: response | |
Influenza Vaccination Strategies Should Target Children | |
The Intensive Care Lifeboat: a survey of lay attitudes to rationing dilemmas in neonatal intensive care | |
Introduction | |
Invisible epidemics: ethics and asymptomatic infection | |
Just liability and reciprocity reasons for treating wounded soldiers. | |
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group | |
Michael L. Gross, Bioethics and Armed Conflict: Moral Dilemmas of Medicine and War | |
Moderate eugenics and human enhancement. | |
A Moderate Pluralist Approach to Public Health Policy and Ethics | |
Module four: standards of care and clinical trials | |
Moral uncertainty and the moral status of early human life. | |
Necessity and least infringement conditions in public health ethics. | |
Neugenics? | |
On the dual uses of science and ethics : principles, practices, and prospects | |
Pandemic and public health controls: toward an equitable compensation system. | |
Pandethics. | |
Placebo use in vaccine trials: recommendations of a WHO expert panel | |
Practical bioethics. | |
Promoting justice, trust, compliance, and health: the case for compensation. | |
Quantifying the impact of individual and collective compliance with infection control measures for ethical public health policy | |
Reflections on the Synthetic Production of Poliovirus | |
A relational approach to saviour siblings? | |
Responsible life sciences research for global health security, 2010: | |
The role of informed consent in tuberculosis testing and screening | |
Should practice and policy be revised to allow for risk-proportional payment to human challenge study participants? | |
Smallpox Revisited? | |
Special double issue of Monash bioethics review inaugurating the Journal's transition to publication by Springer in 2014. | |
Specifying the duty to treat | |
Surveillance and control of asymptomatic carriers of drug-resistant bacteria | |
Synthetic Biology | |
Taking sociology seriously: a new approach to the bioethical problems of infectious disease | |
A tale of two studies; ethics, bioterrorism, and the censorship of science | |
Tensions between research and public health: modelling the risks and benefits of SARS-CoV-2 vaccine field trials versus human infection challenge studies | |
Third human challenge trial conference, Oxford, United Kingdom, February 6-7, 2020, a meeting report | |
Universal norms and conflicting values | |
Unnecessary hesitancy on human vaccine tests-Response | |
Victims, vectors and villains: are those who opt out of vaccination morally responsible for the deaths of others? | |
The World Health Organization, Public Health Ethics, and Surveillance: Essential Architecture for Social Well-Being. | |
Zika, contraception and the non-identity problem. | |
ভূমিকা |